Fosse Park West Nominee Limited
- Company number
- 10940661
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 31 Aug 2017
- Nature of business
- Activities of other holding companies n.e.c.
- Corporate group
- GMV Nominees Ltd (48311 companies)
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| THOMAS, Rhys Edward John | Director | 7 Jan 2025 | 22 Jul 2026 |
| CARTER, Samuel Robert | Director | 22 Jul 2026 | |
| KEIR, David Richard | Director | 7 Jan 2025 | |
| MILNE, Hannah Naomi | Director | 11 Jun 2018 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Fosse Park West Gp Limited | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
31 Aug 2017 |
Accounts
Connections
Owned by
Fosse Park West Nominee Limited → Fosse Park West Gp Limited → Purple Holdco Limited
Directors’ other companies
- CARTER, Samuel Robert - Director at Wexford Retail Gp Limited
- CARTER, Samuel Robert - Director at Maple Nominee Limited
- CARTER, Samuel Robert - Director at Maple Investment Gp Limited
- CARTER, Samuel Robert - Director at Fosse Park West Gp Limited
- CARTER, Samuel Robert - Director at Wexford Retail Nominee Limited
- KEIR, David Richard - Director at Wexford Retail Nominee Limited
- MILNE, Hannah Naomi - Director at Wexford Retail Nominee Limited
Companies at the same address
- Abingworth Avillion Blocker Limited (08298936)
- Abingworth Bioventures 8 LP (LP020555)
- Abingworth Bioventures Gp Limited (08012038)
- Abingworth Bioventures Vi LP (LP015017)
- Abingworth Bioventures Vii LP (LP017463)
- Abingworth Ccd Gp Limited (09622429)
- Abingworth Clinical Co-Development Fund 2 Co-Investment LP (LP021704)
- Abingworth Clinical Co-Development Fund 2 LP (LP021179)
- Abingworth Clinical Co-Development Fund LP (LP016687)
- Abingworth LLP (OC320188)